
Participants will learn about the prevalence, incidence, and economic impact of venous thromboembolism and atrial fibrillation on patients, as well as the associated treatments and clinical data relating to efficacy, safety, and cost-efficacy.
Participants will learn about the prevalence, incidence, and economic impact of venous thromboembolism and atrial fibrillation on patients, as well as the associated treatments and clinical data relating to efficacy, safety, and cost-efficacy.
Published: December 17th 2015 | Updated:
259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512
© 2025 MJH Life Sciences®
All rights reserved.